Shares of Sonova Holding AG (OTCMKTS:SONVY - Get Free Report) have received an average recommendation of "Hold" from the six analysts that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company.
Several equities research analysts have recently weighed in on SONVY shares. HSBC upgraded Sonova to a "buy" rating in a report on Friday, April 25th. Hsbc Global Res raised shares of Sonova from a "hold" rating to a "strong-buy" rating in a research note on Friday, April 25th.
View Our Latest Stock Analysis on SONVY
Sonova Stock Performance
Shares of Sonova stock traded up $1.59 during trading on Tuesday, hitting $62.28. The stock had a trading volume of 16,041 shares, compared to its average volume of 21,393. Sonova has a 12 month low of $52.83 and a 12 month high of $77.56. The firm's fifty day simple moving average is $59.70 and its 200-day simple moving average is $65.51. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.21 and a quick ratio of 0.82.
About Sonova
(
Get Free ReportSonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Featured Stories

Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.